HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

wushanicaritin

from Epimedium wushanense; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        wushanicaritin: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        wushanicaritin: 1

Experts

1.	Gao, Hao: 1 article (03/2018)
2.	Gonzalez, Frank J: 1 article (03/2018)
3.	Hong, Xiaodan: 1 article (03/2018)
4.	Krausz, Kristopher W: 1 article (03/2018)
5.	Li, Shishi: 1 article (03/2018)
6.	Qin, Zifei: 1 article (03/2018)
7.	Wu, Baojian: 1 article (03/2018)
8.	Yao, Xinsheng: 1 article (03/2018)
9.	Yao, Zhihong: 1 article (03/2018)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 03/01/2018 - "Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides."

Related Drugs and Biologics

1.	Multidrug Resistance-Associated Proteins
2.	Glucuronides
3.	Proteins (Proteins, Gene)